- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05375032
Acute Effects of Cycling Dual-task in Parkinson´s Disease.
May 24, 2023 updated by: Iris Machado de Oliveira, University of Vigo
Acute Effects of Cycling Dual-task on Cognitive and Physical Function in Parkinson´s Disease: a Cross-sectional Study.
Taking into account the process of functional and cognitive evolution that patients with Parkinson's disease experience throughout the pathology, the objective of this study is to evaluate the acute effects of aerobic exercise in forced cycling performed with lower limbs and freecycling of upper limbs combined with cognitive stimuli on attention, exploration skills, and short-term motor skills in people with Parkinson's disease.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Iris M de Oliveira, Ph.D.
- Phone Number: 034986801768
- Email: irismacoli@uvigo.es
Study Locations
-
-
-
Pontevedra, Spain, 36004
- University of Vigo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Idiopathic Parkinson's disease
- Present stage between I and III on the Hoenh and Yarh scale
- Being able to move autonomously
Exclusion Criteria:
- Moderate-severe cognitive impairment (Mini-mental test > 24)
- Comorbidity that discourages the practice of physical exercise and that allows performing all scheduled assessments
- Severe visual alterations that prevent the development of the session
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cycling combined with cognitive tasks
|
A 30-minute session of Forced Cycling aerobic exercise performed with lower limbs and free active cycling performed with upper limbs combined with cognitive stimuli.
An intelligent cycle ergometer (Motomed Viva 2 Parkinson) will be used, at a reserve heart rate of 55-70% (Borg scale 12-14) during the active part.
The forced cycling program will consist of a 6-minute passive warm-up part (40-60 RPM), a 20-minute active part (90 RPM), and a 4-minute passive cool down (40 RPM).
The cognitive task will be a PowerPoint presentation structured in a way that is consistent with the phases of the cycling program.
The passive phases (6 minutes of warm-up and 4 minutes of passive cycling back to cool down), images of the nearby environment will be played.
For the active phase (20 minutes of assisted active cycling) the PowerPoint presentation will be structured with tasks related to: orientation, memory, calculation, language, similarities.
Other Names:
|
Active Comparator: Cycling
|
A 30-minute session of Forced Cycling aerobic exercise performed with lower limbs and free active cycling performed with upper limbs combined with cognitive stimuli.
An intelligent cycle ergometer (Motomed Viva 2 Parkinson) will be used, at a reserve heart rate of 55-70% (Borg scale 12-14) during the active part.
The forced cycling program will consist of a 6-minute passive warm-up part (40-60 RPM), a 20-minute active part (90 RPM), and a 4-minute passive cool down (40 RPM).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline Heart Rate at 30 minutes
Time Frame: Pre and up to 30 minutes.
|
Heart rate
|
Pre and up to 30 minutes.
|
Change from baseline Symbol Digit Modalities Test at 30 minutes
Time Frame: Pre and up to 30 minutes.
|
Detection of cognitive dysfuntions.
|
Pre and up to 30 minutes.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Borg Rated Perceived Exertion Scale
Time Frame: Up to 30 minutes.
|
Perceived exertion.
These include a rating of 6 perceiving "no exertion at all" to 20 perceiving a "maximal exertion" of effort.
|
Up to 30 minutes.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Active Distance (m)
Time Frame: During the unique session
|
Cycling active distance in meters.
|
During the unique session
|
Passive Distance (m)
Time Frame: During the unique session
|
Cycling assisted distance in meters.
|
During the unique session
|
Total Work (W)
Time Frame: During the unique session
|
Cycling total work developed in Watts
|
During the unique session
|
Active Speed (rpm)
Time Frame: During the unique session
|
Average cycling active speed in rotation per minute
|
During the unique session
|
Passive Speed (rpm)
Time Frame: During the unique session
|
Average cycling assisted speed in rotation per minute
|
During the unique session
|
Symmetry (%)
Time Frame: During the unique session
|
Percentage of the active work developed by each lower limb, right and left.
|
During the unique session
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 13, 2022
Primary Completion (Actual)
July 31, 2022
Study Completion (Actual)
December 15, 2022
Study Registration Dates
First Submitted
May 2, 2022
First Submitted That Met QC Criteria
May 13, 2022
First Posted (Actual)
May 16, 2022
Study Record Updates
Last Update Posted (Actual)
May 25, 2023
Last Update Submitted That Met QC Criteria
May 24, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 205-2022-2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on Cycling combined with cognitive tasks
-
University of VigoRecruiting
-
University Hospital, Strasbourg, FranceRecruiting
-
William Carey UniversityUniversity of Mississippi Medical Center; University of Southern MississippiCompletedSpinal Cord InjuriesUnited States
-
National Cheng Kung UniversityCompletedDementia | Aging | Cognitive Training | Occupational Therapy | Long Term CareTaiwan
-
Nantes University HospitalCompleted
-
University Hospital, GrenobleCommissariat A L'energie Atomique; Laboratoire de Psychologie et NeuroCognitionCompleted
-
Universidade Federal do Rio Grande do NorteConselho Nacional de Desenvolvimento Científico e TecnológicoCompleted
-
University of California, Los AngelesDanone Nutricia ResearchCompleted
-
University Hospital, GrenobleGrenoble Institut des NeurosciencesRecruitingCognition | Focal Brain InjuryFrance